These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38319449)

  • 1. CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway.
    Liu H; Guo W; Wang T; Cao P; Zou T; Peng Y; Yan T; Liao C; Li Q; Duan Y; Han J; Zhang B; Chen Y; Zhao D; Yang X
    Cell Biol Toxicol; 2024 Feb; 40(1):10. PubMed ID: 38319449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment.
    Liu LZ; Wang B; Zhang R; Wu Z; Huang Y; Zhang X; Zhou J; Yi J; Shen J; Li MY; Dong M
    Cell Death Dis; 2023 Aug; 14(8):548. PubMed ID: 37612265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y; Song T; Shi Z; Li W; Yang S; Li D
    Gene; 2021 Feb; 768():145309. PubMed ID: 33197518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue.
    Nicholls HT; Kowalski G; Kennedy DJ; Risis S; Zaffino LA; Watson N; Kanellakis P; Watt MJ; Bobik A; Bonen A; Febbraio M; Lancaster GI; Febbraio MA
    Diabetes; 2011 Apr; 60(4):1100-10. PubMed ID: 21378177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling.
    Wang J; Ma S; Chen X; Zhang S; Wang Z; Mei Q
    Invest New Drugs; 2019 Oct; 37(5):828-836. PubMed ID: 30456603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity.
    Byun JH; Lebeau PF; Platko K; Carlisle RE; Faiyaz M; Chen J; MacDonald ME; Makda Y; Yousof T; Lynn EG; Dickhout JG; Krepinsky JC; Weaver F; Igdoura SA; Seidah NG; Austin RC
    Kidney360; 2022 Aug; 3(8):1394-1410. PubMed ID: 36176646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
    Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
    IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
    Yang Y; Ikezoe T; Nishioka C; Bandobashi K; Takeuchi T; Adachi Y; Kobayashi M; Takeuchi S; Koeffler HP; Taguchi H
    Br J Cancer; 2006 Dec; 95(12):1653-62. PubMed ID: 17133272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling.
    Hu T; Shen H; Huang H; Yang Z; Zhou Y; Zhao G
    Anticancer Drugs; 2020 Apr; 31(4):377-384. PubMed ID: 32011362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARĪ³/CD36 Pathway in Obese Mice.
    Huang CC; Chou CA; Chen WY; Yang JL; Lee WC; Chen JB; Lee CT; Li LC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
    Yang P; Xiao Y; Luo X; Zhao Y; Zhao L; Wang Y; Wu T; Wei L; Chen Y
    J Lipid Res; 2017 Jul; 58(7):1417-1427. PubMed ID: 28536108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N; Feng T; Liu X; Liu Q
    Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice.
    Li LC; Yang JL; Lee WC; Chen JB; Lee CT; Wang PW; Vaghese Z; Chen WY
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1720-F1731. PubMed ID: 30230367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDC-0349 inhibits non-small cell lung cancer cell growth.
    Yang H; Zhao J; Zhao M; Zhao L; Zhou LN; Duan Y; Li G
    Cell Death Dis; 2020 Nov; 11(11):951. PubMed ID: 33154352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
    Lei W; Huo Z
    Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
    Han L; Wang JN; Cao XQ; Sun CX; Du X
    Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
    Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.